174 related articles for article (PubMed ID: 33288791)
1. The role of IgE specific for galactose-α-1,3-galactose in predicting cetuximab induced hypersensitivity reaction: a systematic review and a diagnostic meta-analysis.
Lungulescu CV; Ungureanu BS; Turcu-Stiolica A; Ghimpau V; Artene SA; Cazacu IM; Grecu AF; Dinescu VC; Croitoru A; Volovat SR
Sci Rep; 2020 Dec; 10(1):21355. PubMed ID: 33288791
[TBL] [Abstract][Full Text] [Related]
2. Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab.
Serrier J; Davy JB; Dupont B; Clarisse B; Parienti JJ; Petit G; Khoy K; Ollivier Y; Gervais R; Mariotte D; Le Mauff B
BMC Cancer; 2023 Jan; 23(1):32. PubMed ID: 36624467
[TBL] [Abstract][Full Text] [Related]
3. A novel approach to predict cetuximab-induced hypersensitivity reaction: detection of drug-specific IgE on basophils.
Iwamoto T; Okamoto A; Ishinaga H; Shimizu K; Gayle AA; Arai N; Takeuchi K; Okuda M
Cancer Med; 2016 Jun; 5(6):1004-12. PubMed ID: 26880699
[TBL] [Abstract][Full Text] [Related]
4. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose.
Chung CH; Mirakhur B; Chan E; Le QT; Berlin J; Morse M; Murphy BA; Satinover SM; Hosen J; Mauro D; Slebos RJ; Zhou Q; Gold D; Hatley T; Hicklin DJ; Platts-Mills TA
N Engl J Med; 2008 Mar; 358(11):1109-17. PubMed ID: 18337601
[TBL] [Abstract][Full Text] [Related]
5. Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.
Dupont B; Mariotte D; Dugué AE; Clarisse B; Grellard JM; Babin E; Chauffert B; Dakpé S; Moldovan C; Bouhier-Leporrier K; Reimund JM; Di Fiore F; Zanetta S; Mailliez A; Do P; Peytier A; Galais MP; Florescu C; Schott R; Le Mauff B; Gervais R
Br J Clin Pharmacol; 2017 Mar; 83(3):623-631. PubMed ID: 27662818
[TBL] [Abstract][Full Text] [Related]
6. Anaphylaxis to the carbohydrate side chain alpha-gal.
Platts-Mills TA; Schuyler AJ; Tripathi A; Commins SP
Immunol Allergy Clin North Am; 2015 May; 35(2):247-60. PubMed ID: 25841549
[TBL] [Abstract][Full Text] [Related]
7. Alpha-gal is a possible target of IgE-mediated reactivity to antivenom.
Fischer J; Eberlein B; Hilger C; Eyer F; Eyerich S; Ollert M; Biedermann T
Allergy; 2017 May; 72(5):764-771. PubMed ID: 27775867
[TBL] [Abstract][Full Text] [Related]
8. Drug allergens and food--the cetuximab and galactose-α-1,3-galactose story.
Berg EA; Platts-Mills TA; Commins SP
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):97-101. PubMed ID: 24468247
[TBL] [Abstract][Full Text] [Related]
9. Cohort study of subclinical sensitization against galactose-α-1,3-galactose in Japan: Prevalence and regional variations.
Nakagawa Y; Chinuki Y; Ogino R; Yamasaki K; Aiba S; Ugajin T; Yokozeki H; Kitamura K; Morita E
J Dermatol; 2022 Dec; 49(12):1268-1277. PubMed ID: 36093796
[TBL] [Abstract][Full Text] [Related]
10. Meat allergy associated with galactosyl-α-(1,3)-galactose (α-Gal)-Closing diagnostic gaps by anti-α-Gal IgE immune profiling.
Jappe U; Minge S; Kreft B; Ludwig A; Przybilla B; Walker A; Varga R; Seidel P; Biedermann T; Anemüller W; Kromminga A; Ruëff F; Merk H; Wagner N; Treudler R; Worm M; Waldmann I; Saloga J; Becker WM; Goldmann T; Platts-Mills TA; Homann A
Allergy; 2018 Jan; 73(1):93-105. PubMed ID: 28670695
[TBL] [Abstract][Full Text] [Related]
11. Galactose-α-1,3-Galactose: Atypical Food Allergen or Model IgE Hypersensitivity?
Wilson JM; Schuyler AJ; Schroeder N; Platts-Mills TA
Curr Allergy Asthma Rep; 2017 Jan; 17(1):8. PubMed ID: 28224342
[TBL] [Abstract][Full Text] [Related]
12. Risk factors associated with hypersensitivity reactions to cetuximab: anti-cetuximab IgE detection as screening test.
Dupont B; Mariotte D; Clarisse B; Galais MP; Bouhier-Leporrier K; Grellard JM; Le Mauff B; Reimund JM; Gervais R
Future Oncol; 2014 Nov; 10(14):2133-40. PubMed ID: 25471028
[TBL] [Abstract][Full Text] [Related]
13. Laminin γ-1 and collagen α-1 (VI) chain are galactose-α-1,3-galactose-bound allergens in beef.
Takahashi H; Chinuki Y; Tanaka A; Morita E
Allergy; 2014 Feb; 69(2):199-207. PubMed ID: 24180678
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Alpha-Gal-containing biologics and anaphylaxis.
Chinuki Y; Morita E
Allergol Int; 2019 Jul; 68(3):296-300. PubMed ID: 31053502
[TBL] [Abstract][Full Text] [Related]
16. Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigation.
Yuile A; Fanuli C; van Nunen S; Diakos C; Clarke S; Steiner C; MacMillan R; Oatley M; Pavlakis N
Asia Pac J Clin Oncol; 2021 Dec; 17(6):448-453. PubMed ID: 32970939
[TBL] [Abstract][Full Text] [Related]
17. Food allergy to the carbohydrate galactose-alpha-1,3-galactose (alpha-gal): four case reports and a review.
Bircher AJ; Hofmeier KS; Link S; Heijnen I
Eur J Dermatol; 2017 Feb; 27(1):3-9. PubMed ID: 27873733
[TBL] [Abstract][Full Text] [Related]
18. Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis.
Mariotte D; Dupont B; Gervais R; Galais MP; Laroche D; Tranchant A; Comby E; Bouhier-Leporrier K; Reimund JM; Le Mauff B
MAbs; 2011; 3(4):396-401. PubMed ID: 21654207
[TBL] [Abstract][Full Text] [Related]
19. Allergenicity of carbohydrates and their role in anaphylactic events.
Commins SP; Platts-Mills TA
Curr Allergy Asthma Rep; 2010 Jan; 10(1):29-33. PubMed ID: 20425511
[TBL] [Abstract][Full Text] [Related]
20. Skin prick test and basophil reactivity to cetuximab in patients with IgE to alpha-gal and allergy to red meat.
Michel S; Scherer K; Heijnen IA; Bircher AJ
Allergy; 2014 Mar; 69(3):403-5. PubMed ID: 24372137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
